Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer

Abstract

This indicates that epigenetic changes affect the expression of the Smad4 protein in prostate cancer and points to methylation of the promoter as a novel marker of and contributor to the disease warranting further study.